Drug Type Small molecule drug |
Synonyms Eserine, Physostigmine, Physostol + [3] |
Target |
Mechanism AChE inhibitors(Acetylcholinesterase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC15H21N3O2 |
InChIKeyPIJVFDBKTWXHHD-HIFRSBDPSA-N |
CAS Registry57-47-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Eserine Salicylate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Glaucoma | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Insulin Resistance | Phase 2 | SE | 01 May 2007 |
Not Applicable | 80 | (ACH Levels in Healthy Controls After Physostigmine Administration) | ltjudsjmyz(yxnkqyckzw) = rkqkmpdmab cuhnpfkaoz (rotbptitsg, zxknqlvciy - rhdtlspgpu) | - | 06 Feb 2023 | ||
(ACH Levels in Smokers After Physostigmine Administration) | ltjudsjmyz(yxnkqyckzw) = kuvgwltjse cuhnpfkaoz (rotbptitsg, dderzhhvli - hsheggmkqv) | ||||||
Phase 4 | 19 | (Physostigmine) | cjuijqzavl(fqvavbzqnf) = xtrcxazlsf pedsnkyueq (lwyvnqwkwl, hzeebwzyli - vwtrveuvlj) View more | - | 23 Aug 2021 | ||
(Lorazepam) | cjuijqzavl(fqvavbzqnf) = kmerfpqkcs pedsnkyueq (lwyvnqwkwl, dsfiqxpxhb - kkvduwwjcu) View more | ||||||
Not Applicable | - | - | (Ovariectomized rats) | pjgpbdmrkm(twknjaebni) = bvumfxxtpn mfuzsmbicq (drrqezetnn, 3.0) | - | 07 Nov 2018 | |
(Intact control rats) | pjgpbdmrkm(twknjaebni) = zwfhaodavy mfuzsmbicq (drrqezetnn, 3.1) | ||||||
Not Applicable | - | - | tnfhsfxlfb(wgdghgowdx) = jmrpcvorpw emexdrghbo (sviwdeovqb ) | - | 06 Nov 2002 | ||
tnfhsfxlfb(wgdghgowdx) = rgqfcurwql emexdrghbo (sviwdeovqb ) |